Myriad Genetics Inc
MYGN
Common Stock
$19.87
Sector: Health Care
Industry: Biotechnology
Sub-Industry: Biotechnology
|
|
|
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$1.39 | -$0.35 | -$2.69 | $0.06 | $1.85 |
Sales/Revenue | $678.40 M | $690.60 M | $638.60 M | $851.10 M | $743.70 M |
Sales Growth | -1.77% | 8.14% | -24.97% | 14.44% | 0.00% |
Gross Margin | +64.17 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$112.00 M | -$27.20 M | -$199.50 M | $4.60 M | $133.30 M |
Net Income Growth | -311.76% | 86.37% | -4436.96% | -96.55% | 0.00% |
Net Margin | -16.51 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$53.90 M | -$49.30 M | -$62.80 M | $111.60 M | $115.10 M |
Cost of Goods Sold (incl D&A) | $243.10 M | $248.30 M | $247.10 M | $260.30 M | $214.50 M |
Cost of Goods Sold (excl D&A) | $178.70 M | $172.70 M | $175.10 M | $187.30 M | $160.10 M |
Cost of Goods Growth | -2.09% | 0.49% | -5.07% | 21.35% | 0.00% |
Research & Development | $85.40 M | $81.90 M | $77.20 M | $85.90 M | $70.80 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $449.10 M | $466.30 M | $397.70 M |
Interest Expense | $3.20 M | $6.60 M | $10.80 M | $12.00 M | $3.20 M |
Income Tax | -$28.60 M | -$29.90 M | -$23.70 M | -$4.40 M | -$13.00 M |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.52 | -$0.43 | -$0.18 | -$0.26 |
Sales/Revenue | $177.80 M | $156.40 M | $179.30 M | $164.90 M |
Sales Growth | 13.68% | -12.77% | 8.73% | 2.55% |
Gross Margin | +64.17 | 0.00 | 0.00 | 0.00 |
Net Income | -$42.30 M | -$35.10 M | -$14.10 M | -$20.50 M |
Net Income Growth | -20.51% | -148.94% | 31.22% | -169.74% |
Net Margin | -16.51 | 0.00 | 0.00 | 0.00 |
EBITDA | -$24.30 M | -$29.00 M | -$4.80 M | $1.70 M |
Cost of Goods Sold (incl D&A) | $64.40 M | $60.60 M | $59.90 M | $58.20 M |
Cost of Goods Sold (excl D&A) | $47.70 M | $44.60 M | $46.90 M | $42.10 M |
Cost of Goods Growth | 6.27% | 1.17% | 2.92% | 4.11% |
Research & Development | $23.40 M | $20.50 M | $20.30 M | $21.20 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Interest Expense | $0.90 M | $0.80 M | $0.60 M | $0.90 M |
Income Tax | -$9.80 M | -$9.10 M | -$3.80 M | -$5.90 M |
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $187.00 M | $125.00 M | $103.00 M | $57.00 M | $43.00 M |
Cash and Short-Term Investment | $117.00 M | $340.00 M | $218.00 M | $137.00 M | $181.00 M |
Cash and Short-Term Investment Growth | -65.60% | 56.01% | 59.09% | -24.20% | 0.00% |
Long Term Debt | $131.00 M | $79.00 M | $281.00 M | $234.00 M | $9.00 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $1.32 B | $1.41 B | $1.54 B | $1.67 B | $1.23 B |
Total Assets Growth | -6.81% | -8.46% | -7.30% | 35.70% | 0.00% |
Inventories | $20.00 M | $15.00 M | $29.00 M | $31.00 M | $34.00 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $14.00 M | $13.00 M | $14.00 M | $0.00 M | $0.00 M |
Total Liabilities | $431.00 M | $446.00 M | $626.00 M | $577.00 M | $261.00 M |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $187.00 M | $178.00 M | $136.00 M | $117.00 M | $125.00 M |
Cash and Short-Term Investment | $117.00 M | $193.00 M | $205.00 M | $268.00 M | $340.00 M |
Cash and Short-Term Investment Growth | -39.49% | -5.80% | -23.58% | -21.01% | 0.00% |
Long Term Debt | $131.00 M | $123.00 M | $87.00 M | $77.00 M | $79.00 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $1.32 B | $1.21 B | $1.21 B | $1.26 B | $1.41 B |
Total Assets Growth | 8.68% | 0.15% | -3.60% | -11.19% | 0.00% |
Inventories | $20.00 M | $20.00 M | $15.00 M | $16.00 M | $15.00 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $14.00 M | $14.00 M | $13.00 M | $13.00 M | $13.00 M |
Total Liabilities | $431.00 M | $295.00 M | $263.00 M | $305.00 M | $446.00 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2024-08-16 | 0.21 | -$6.70 K |
Quarter | Amount | Yield |
---|
|
|